Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
454.00    -1.50 (-0.33%)
Bid:
452.50
Ask:
453.50
Spread: 1.00 (0.221%)
Market Cap: £670.71m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Director/PDMR Shareholding

2 Sep 2005 09:42

Creston PLC02 September 2005 2 September 2005 Creston Plc (the "Company")Grant of Options and of Restricted Shares under the Creston Long Term IncentivePlan On 31 August 2005 the Board approved the following grant of options pursuant toan agreement dated 3 January 2001, to Mr D.H Elgie a Director of the Company. The grant of options is as a result of the issue and allotment of new ordinaryshares relating to the issue of shares in connection with the acquisition of RedDoor Communications Limited. The details are as follows: Name Exercise No. of options Exercise period Price Don Elgie 31 August 2008 -30 August 2015 20,078 165.5p Of the options outlined above, 10,039 are performance related options, which canbe exercised after the initial exercise date provided Creston Plc's averagegrowth in diluted earnings per share has for two consecutive financial yearsexceeded the average growth in diluted earnings per share of such competitorcompanies (as specified by the Company's brokers) by greater than 10 per cent. In addition to the options outlined above, Mr Elgie has an interest in thefollowing: • 605,060 options over ordinary shares, at an exercise price of 95p • 382,380 options over ordinary shares, at an exercise price of 110p • 60,657 options over ordinary shares, at an exercise price of 114p • 91,145 options over ordinary shares, at an exercise price of 113p • 46,752 options over ordinary shares, at an exercise price of 139p • 6,930 options over ordinary shares, at an exercise price of 136p • 67,477 options over ordinary shares, at an exercise price of 142p • 487,280 options over ordinary shares, at an exercise price of 155p • 24,231 options over ordinary shares, at an exercise price of 165.5p In addition, the following awards were made to senior executives under theCreston plc Long Term Incentive Plan (the "Plan") in respect of 229,734 ordinaryshares of 10 pence each, which included the following awards made to Directorsand members of the Creston Operating Board. Name Position Number of ordinary shares Don Elgie Chief Executive 21,926 Keith Bates Managing Director, Marketing Sciences Group 43,729 Graham Monk Managing Director, TRA Limited 44,487 No payment was made for the grant of these awards and these shares will be heldby the Creston Employees Benefit Trust and will vest and be released to theaward holders for nil cost under the rules of the Plan. Subject to the rules ofthe Plan and the satisfaction of the performance conditions, these awards areanticipated to vest on the date of the announcement of the preliminary resultsof the Company in respect of the years ended 31 March 2007 and 2008. In addition to the award under the Plan outlined above, Mr. Bates and Mr Monkalso have a beneficial interest in 633,620 and 9,500 ordinary sharesrepresenting 1.73 per cent. and 0.03 per cent. of the issued ordinary sharecapital of the Company respectively. Mr Elgie also has a beneficial interest in997,801 ordinary shares in the Company representing 2.73 per cent of theCompany's issued ordinary share capital of the company. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Jun 20267:00 amRNSTransaction in Own Shares
16th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
26th May 20262:53 pmRNS$50 million Share Buyback Programme
20th May 20267:00 amRNSHolding(s) in Company
19th May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSHolding(s) in Company
14th May 20267:00 amRNSResult of AGM
13th May 20267:00 amRNSTrading Update for Q1 2026
12th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSNotice of Q1 2026 Trading Update
28th Apr 20267:00 amRNSDirectorate change
28th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSHolding(s) in Company
21st Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20264:54 pmRNSDirector/PDMR Shareholding
10th Apr 20264:26 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20265:56 pmRNSNotice of AGM
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSHolding(s) in Company
30th Mar 20265:27 pmRNSDirector/PDMR Shareholding
30th Mar 20265:26 pmRNSDirector/PDMR Shareholding
30th Mar 20265:26 pmRNSDirector/PDMR Shareholding
30th Mar 20265:26 pmRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSDirectorate change
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20263:06 pmRNSDirectorate change
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.